PGNY Progyny Inc

Price (delayed)

$28.8

Market cap

$2.74B

P/E Ratio

44.31

Dividend/share

N/A

EPS

$0.65

Enterprise value

$2.64B

Progyny is a leading fertility benefits management company in the US. The company is redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously ...

Highlights
The net income has grown by 42% YoY
The EPS has grown by 38% year-on-year

Key stats

What are the main financial stats of PGNY
Market
Shares outstanding
95.22M
Market cap
$2.74B
Enterprise value
$2.64B
Valuations
Price to book (P/B)
4.86
Price to sales (P/S)
2.51
EV/EBIT
35.85
EV/EBITDA
34.69
EV/Sales
2.39
Earnings
Revenue
$1.11B
EBIT
$73.76M
EBITDA
$76.22M
Free cash flow
$190.34M
Per share
EPS
$0.65
Free cash flow per share
$1.97
Book value per share
$5.92
Revenue per share
$11.49
TBVPS
$8.11
Balance sheet
Total assets
$794.3M
Total liabilities
$222.7M
Debt
$16.78M
Equity
$571.6M
Working capital
$475.59M
Liquidity
Debt to equity
0.03
Current ratio
3.31
Quick ratio
3.25
Net debt/EBITDA
-1.29
Margins
EBITDA margin
6.9%
Gross margin
21.9%
Net margin
5.5%
Operating margin
5.9%
Efficiency
Return on assets
8.3%
Return on equity
11.6%
Return on invested capital
17.8%
Return on capital employed
12.5%
Return on sales
6.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PGNY stock price

How has the Progyny stock price performed over time
Intraday
2.93%
1 week
2.78%
1 month
8.6%
1 year
-26.87%
YTD
-22.54%
QTD
0.66%

Financial performance

How have Progyny's revenue and profit performed over time
Revenue
$1.11B
Gross profit
$242.57M
Operating income
$65.7M
Net income
$61.26M
Gross margin
21.9%
Net margin
5.5%
Progyny's operating income has surged by 71% YoY and by 6% QoQ
The net income has grown by 42% YoY
PGNY's operating margin is up by 34% year-on-year and by 3.5% since the previous quarter
The revenue is up by 27% year-on-year

Growth

What is Progyny's growth rate over time

Valuation

What is Progyny stock price valuation
P/E
44.31
P/B
4.86
P/S
2.51
EV/EBIT
35.85
EV/EBITDA
34.69
EV/Sales
2.39
The EPS has grown by 38% year-on-year
The stock's price to earnings (P/E) is 31% less than its last 4 quarters average of 62.7
PGNY's price to book (P/B) is 67% lower than its 5-year quarterly average of 14.4 and 31% lower than its last 4 quarters average of 6.8
PGNY's equity is up by 35% year-on-year and by 3.3% since the previous quarter
PGNY's price to sales (P/S) is 62% lower than its 5-year quarterly average of 6.4 and 28% lower than its last 4 quarters average of 3.4
The revenue is up by 27% year-on-year

Efficiency

How efficient is Progyny business performance
The return on sales has grown by 49% year-on-year and by 8% since the previous quarter
PGNY's return on invested capital is up by 23% year-on-year but it is down by 2.2% since the previous quarter
The company's return on equity fell by 8% QoQ
Progyny's return on assets has decreased by 6% QoQ but it has increased by 3.8% YoY

Dividends

What is PGNY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGNY.

Financial health

How did Progyny financials performed over time
Progyny's current ratio has increased by 30% YoY but it has decreased by 3.8% QoQ
PGNY's quick ratio is up by 29% year-on-year
The company's debt is 97% lower than its equity
PGNY's equity is up by 35% year-on-year and by 3.3% since the previous quarter
PGNY's debt to equity is down by 25% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.